Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-44.72M
↓ 163% below average
Average (5y)
$-16.99M
Historical baseline
Range
High:$134.19M
Low:$-96.67M
CAGR
+31.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-44.72M | -133.3% |
| 2023 | $134.19M | +238.8% |
| 2022 | $-96.67M | -74.4% |
| 2021 | $-55.44M | -98.8% |
| 2020 | $-27.89M | -144.0% |
| 2019 | $-11.43M | - |